Mark Willis

Association of Initial Disease-Modifying Therapy With Later Conversion to Secondary Progressive Multiple Sclerosis

J William L Brown, Alasdair Coles, Dana Horáková et al. · JAMA · 2019 · 547 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +14

Clinical Outcomes of Escalation vs Early Intensive Disease-Modifying Therapy in Patients With Multiple Sclerosis

Katharine Harding, Owain Williams, Mark Willis et al. · JAMA Neurology · 2019 · 364 citations · Full text

Medicine, Internal Medicine, Neurology +14

Treatment effectiveness of alemtuzumab compared with natalizumab, fingolimod, and interferon beta in relapsing-remitting multiple sclerosis: a cohort study

Tomáš Kalinčík, J William L Brown, Neil P. Robertson et al. · The Lancet Neurology · 2017 · 162 citations · Full text

Life Sciences, Neurology, Pharmacotherapy +16

<scp>COVID</scp> ‐19 Vaccine Response in People with Multiple Sclerosis

Emma Tallantyre, Nicola Vickaryous, Valerie Anderson et al. · Annals of Neurology · 2021 · 152 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Still no archaeological evidence that Neanderthals created Iberian cave art

Randall White, Gerhard Bosinski, Raphaëlle Bourrillon et al. · Journal of Human Evolution · 2019 · 147 citations · Full text

Humanities, Anthropology, Archaeology +14